foxo4 dri senolytic 2023 2024 The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Senotherapy for chronic lung disease
Senotherapy for chronic lung disease ScienceDirect Targeting the FOXO4 p53 axis by retro inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline Naunyn Schmiedeberg's Archives of Pharmacology Springer Nature Link Senolytics & Cellular Senescence Explained Why Im Waiting on FOXO4 DRI FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




